z-logo
open-access-imgOpen Access
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3 -Mutated AML
Author(s) -
Roby P. Bhattacharyya,
William P. Hanage,
T Harvard
Publication year - 2022
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmx220003
Subject(s) - medicine , refractory (planetary science) , chemotherapy , oncology , cancer research , astrobiology , physics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom